Point72 Asset Management
CABA icon

Point72 Asset Management’s Cabaletta Bio CABA Stock Holding History

Point72 Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$663K Buy
246,615
+189,967
+335% +$527K ﹤0.01% 2997
2025
Q4 		$124K Buy
+56,648
New +$140K ﹤0.01% 3713
2025
Q1 		– Sell
-1,265,882
Closed -$2.87M – 2077
2024
Q4 		$2.87M Buy
1,265,882
+598,607
+90% +$2.1M 0.01% 1125
2024
Q3 		$3.15M Buy
+667,275
New +$3.86M 0.01% 1023
2024
Q2 		– Sell
-282,651
Closed -$4.82M – 1896
2024
Q1 		$4.82M Sell
282,651
-2,015
-0.7% -$43.2K 0.01% 976
2023
Q4 		$6.46M Buy
+284,666
New +$4.79M 0.02% 828
2023
Q2 		– Sell
-5,243
Closed -$43.4K – 2211
2023
Q1 		$43.4K Buy
+5,243
New +$49.1K ﹤0.01% 1811
2022
Q2 		– Sell
-725,000
Closed -$1.47M – 1418
2022
Q1 		$1.47M Sell
725,000
-225,000
-24% -$588K 0.01% 915
2021
Q4 		$3.6M Buy
950,000
+50,000
+6% +$534K 0.01% 738
2021
Q3 		$10.9M Buy
+900,000
New +$8.3M 0.05% 463

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management's CABA Position: Q1 2026 in Review

Point72 Asset Management increased its Cabaletta Bio (CABA) stake by 335% in Q1 2026, buying an estimated $527K and bringing the position to 246,615 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Point72 Asset Management first reported a position in CABA in Q3 2021 and has held it in 10 quarters since. The position peaked at $10.9M in Q3 2021. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Point72 Asset Management held 246,615 shares of Cabaletta Bio worth $663K as of Q1 2026.
  • Point72 Asset Management bought 189,967 Cabaletta Bio shares in Q1 2026, an estimated $527K.
  • Cabaletta Bio made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2997 holding.
  • Point72 Asset Management first reported a position in Cabaletta Bio in Q3 2021 and has held it in 10 quarters since.
  • Point72 Asset Management's Cabaletta Bio position peaked at $10.9M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.